Chi-square tests were performed to assess if the percentage of patients receiving testing was statistically significant across clinics.
When patients receive tests that aren't needed, there is a reasonable chance that doctors are using the results to make choices about treatment; by definition, these choices have a higher danger of being flawed.
In this strictly observational registry, only 12% of the patients received tests entirely within the guideline recommendations for initial investigation before receiving the ILR, which is a very important finding, since it implies that the messages and recommendations of current guidelines are not known or at least not followed.
The proportions of patients receiving other tests were estimated from NAMCS data and the literature [ 32].
Second, the percentage of patients receiving laboratory tests recommended by the NKF KDOQI standard was low, even in those patients seen by a nephrologist.
The proportions of patients receiving other tests on follow-up were as follows: 11% urinalysis, 4% ultrasound of bladder or bladder function studies, 2% spinal tap, and 2% electromyography.
However, given the significant lack of recall in patients receiving the test result, the CAN test did not seem to produce fear or anxiety, but rather a request for more information on the test and the meaning of results.
The panel provided detailed information on the hyponatremia-related tests and procedures that are performed in each treatment setting, and the proportion of patients receiving each test or procedure.
The number of patients receiving each test and procedure at initial evaluation and follow-up were multiplied by unit prices to determine the contribution of tests and procedures to the total cost of illness.
All patients receiving the test drug were included in the safety analysis.
When the health systems costs were factored in, plus the outcomes for patients receiving each test were considered, Xpert MTB-RIF was the most cost-effective tool for diagnosing TB.
